Key Details
Price
$84.06Last Dividend
$0.26Annual Revenue
$9.46 BAnnual EPS
$1.96Annual ROE
4.83%Beta
0.64Events Calendar
Next earnings date:
Feb 28, 2025Recent quarterly earnings:
Nov 12, 2024Recent annual earnings:
Feb 28, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
May 14, 2024Next split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
Market Data
Dividend
Profitability
Efficiency
Valuation
Liquidity
Cash Flow
Institutional Ownership
GENEVA--(BUSINESS WIRE)--Alcon will be speaking at the 2025 Annual J.P. Morgan Healthcare Conference.
No matter if you focus on value, growth, or momentum investing, discovering solid stocks is simpler with the Zacks Style Scores, which is a key part of the Zacks Premium research service.
I maintain a 'Strong Buy' recommendation for Alcon, setting a one-year price target of $118 per share, even with a slight reduction in guidance. The company's new products, like PRECISION7 and Systane Pro, are anticipated to boost growth in the vision sector. Additionally, Alcon's surgical division, which excels in cataract surgery, is expected to grow by 7% each year due to innovative technology and global expansion.
ALC's success is fueled by high demand for its creative products, a well-distributed presence in different regions, and the team's effective performance.
The eye-care company Alcon lowered its predictions for 2024 and did not meet market expectations for its third-quarter sales, which were announced on Tuesday evening. This was mainly due to a weak U.S. market affecting its surgical division.
The financial results for Alcon (ALC) from the quarter ending in September 2024 provide insight into the company's performance. It may also be helpful to compare some important metrics with Wall Street predictions and figures from the same period last year.
ST. CATHARINES, Ontario--(BUSINESS WIRE)-- #yourmarinecarrierofchoice--Algoma Central Corporation (TSX: ALC) has announced that it will share its financial results for the three and nine months ending September 30, 2024, before the market opens on November 4, 2024. The earnings report and complete financial details will be accessible on the Company's website and SEDAR. Algoma Central Corporation is a worldwide provider of marine transportation, operating dry and liquid bulk carriers to serve various markets.
The significant growth in the Surgical and Vision Care sectors is boosting investors' confidence in ALC.
ALC is experiencing good growth in Vision Care due to strong sales of its contact lenses and eye health products.
Bausch + Lomb's stock rose sharply on Monday, briefly reaching new highs, after news emerged that the company is consulting with advisors to consider a possible sale.
FAQ
- What is the primary business of Alcon?
- What is the ticker symbol for Alcon?
- Does Alcon pay dividends?
- What sector is Alcon in?
- What industry is Alcon in?
- What country is Alcon based in?
- When did Alcon go public?
- Is Alcon in the S&P 500?
- Is Alcon in the NASDAQ 100?
- Is Alcon in the Dow Jones?
- When was Alcon's last earnings report?
- When does Alcon report earnings?
- Should I buy Alcon stock now?